MULTI-001 Nivolumab v7 MULTI-002 Carboplatin and etoposide v1 MULTI-003 Pembrolizumab v9 MULTI-018 Larotrectinib v2 MULTI-019 Entrectinib v1 MULTI-020 Dabrafenib with Trametinib v1
SKI-005 Vismodegib v2 SKI-009 Ipilimumab & Nivolumab v3 SKI-011 Avelumab for Merkel Cell Carcinoma v2 SKI-012 Talimogene laherparepvec v1 SKI-014 Encorafenib & Binimetinib v1 SKI-015 Cemiplimab v1
